These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3729592)

  • 1. Effect of age on the disposition of proguanil in man.
    Ogunbona FA; Olowu AO
    Ann Trop Med Parasitol; 1986 Feb; 80(1):123-4. PubMed ID: 3729592
    [No Abstract]   [Full Text] [Related]  

  • 2. Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man.
    Edstein MD; Veenendaal JR; Scott HV; Rieckmann KH
    Chemotherapy; 1988; 34(5):385-92. PubMed ID: 3180907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.
    Ward SA; Watkins WM; Mberu E; Saunders JE; Koech DK; Gilles HM; Howells RE; Breckenridge AM
    Br J Clin Pharmacol; 1989 Jun; 27(6):781-7. PubMed ID: 2757894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism.
    Helsby NA; Ward SA; Edwards G; Howells RE; Breckenridge AM
    Br J Clin Pharmacol; 1990 Oct; 30(4):593-8. PubMed ID: 2291871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the polymorphic oxidation of debrisoquine and proguanil in a Khmer (Cambodian) population.
    Wanwimolruk S; Thou MR; Woods DJ
    Br J Clin Pharmacol; 1995 Aug; 40(2):166-9. PubMed ID: 8562301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic oxidative metabolism of proguanil in a Nigerian population.
    Bolaji OO; Sadare IO; Babalola CP; Ogunbona FA
    Eur J Clin Pharmacol; 2002 Nov; 58(8):543-5. PubMed ID: 12451432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiments with antimalarial drugs in man. V. Experiments with an active metabolite of proguanil and an active metabolite of 5943.
    ROBERTSON GI
    Trans R Soc Trop Med Hyg; 1957 Nov; 51(6):488-92. PubMed ID: 13496181
    [No Abstract]   [Full Text] [Related]  

  • 8. Disposition of proguanil in Thai patients with uncomplicated falciparum malaria.
    Edstein MD; Looareesuwan S; Wilairatana P; Vanijanonta S; Kyle DE; Rieckmann KH
    Am J Trop Med Hyg; 1997 May; 56(5):498-502. PubMed ID: 9180597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments.
    Funck-Brentano C; Becquemont L; Lenevu A; Roux A; Jaillon P; Beaune P
    J Pharmacol Exp Ther; 1997 Feb; 280(2):730-8. PubMed ID: 9023285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese poor metabolizers of proguanil do not have an increased risk of malaria chemoprophylaxis breakthrough.
    Mberu EK; Wansor T; Sato H; Nishikawa Y; Watkins WM
    Trans R Soc Trop Med Hyg; 1995; 89(6):658-9. PubMed ID: 8594689
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic disposition of proguanil in extensive and poor metabolisers of S-mephenytoin 4'-hydroxylation recruited from an Indonesian population.
    Setiabudy R; Kusaka M; Chiba K; Darmansjah I; Ishizaki T
    Br J Clin Pharmacol; 1995 Mar; 39(3):297-303. PubMed ID: 7619672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple qualitative test for the presence of both proguanil and dapsone in urine after oral ingestion.
    Kreutzmann DJ
    Trans R Soc Trop Med Hyg; 1970; 64(1):198. PubMed ID: 5442071
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
    Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
    J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism--a panel study.
    Ward SA; Helsby NA; Skjelbo E; Brøsen K; Gram LF; Breckenridge AM
    Br J Clin Pharmacol; 1991 Jun; 31(6):689-92. PubMed ID: 1867963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark.
    Brøsen K; Skjelbo E; Flachs H
    Br J Clin Pharmacol; 1993 Aug; 36(2):105-8. PubMed ID: 8398577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects.
    Wattanagoon Y; Taylor RB; Moody RR; Ochekpe NA; Looareesuwan S; White NJ
    Br J Clin Pharmacol; 1987 Dec; 24(6):775-80. PubMed ID: 3440097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone.
    Hussein Z; Eaves CJ; Hutchinson DB; Canfield CJ
    Br J Clin Pharmacol; 1996 Nov; 42(5):589-97. PubMed ID: 8951190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pharmacokinetics of proguanil and its metabolites.
    Bygbjerg I; Ravn P; Rønn A; Flachs H; Hvidberg EF
    Trop Med Parasitol; 1987 Jun; 38(2):77-80. PubMed ID: 3629140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults.
    Watkins WM; Mberu EK; Nevill CG; Ward SA; Breckenridge AM; Koech DK
    Trans R Soc Trop Med Hyg; 1990; 84(4):492-5. PubMed ID: 2091335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of honey on CYP3A4, CYP2D6 and CYP2C19 enzyme activity in healthy human volunteers.
    Tushar T; Vinod T; Rajan S; Shashindran C; Adithan C
    Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):269-72. PubMed ID: 17371531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.